Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.8K Buy
119,227
+52,532
+79% +$49K ﹤0.01% 3645
2025
Q4
$103K Sell
66,695
-4,975
-7% -$7.95K ﹤0.01% 3633
2025
Q3
$113K Buy
71,670
+21,049
+42% +$36.6K ﹤0.01% 3667
2025
Q2
$110K Buy
50,621
+3,780
+8% +$9.15K ﹤0.01% 3641
2025
Q1
$128K Sell
46,841
-2,255
-5% -$8.89K ﹤0.01% 3595
2024
Q4
$204K Buy
49,096
+3,848
+9% +$14.5K ﹤0.01% 3507
2024
Q3
$176K Sell
45,248
-222
-0.5% -$935 ﹤0.01% 3540
2024
Q2
$178K Sell
45,470
-1,769
-4% -$7.61K ﹤0.01% 3652
2024
Q1
$198K Sell
47,239
-19,346
-29% -$90.8K ﹤0.01% 3648
2023
Q4
$313K Buy
66,585
+34,917
+110% +$136K ﹤0.01% 3421
2023
Q3
$98.8K Buy
31,668
+832
+3% +$3.35K ﹤0.01% 3722
2023
Q2
$142K Sell
30,836
-1,416
-4% -$6.51K ﹤0.01% 3675
2023
Q1
$160K Sell
32,252
-2,024
-6% -$9.97K ﹤0.01% 3655
2022
Q4
$187K Sell
34,276
-73
-0.2% -$448 ﹤0.01% 3700
2022
Q3
$223K Sell
34,349
-8,157
-19% -$45.5K ﹤0.01% 3644
2022
Q2
$201K Buy
42,506
+4,334
+11% +$21.3K ﹤0.01% 3725
2022
Q1
$267K Buy
38,172
+277
+0.7% +$1.89K ﹤0.01% 3682
2021
Q4
$386K Buy
+37,895
New +$407K ﹤0.01% 3498

Other funds holding MXCT

Invesco's MXCT Position: Q1 2026 in Review

Invesco increased its MaxCyte (MXCT) stake by 79% in Q1 2026, buying an estimated $49K and bringing the position to 119,227 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

Invesco first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $386K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Invesco held 119,227 shares of MaxCyte worth $83.8K as of Q1 2026.
  • Invesco bought 52,532 MaxCyte shares in Q1 2026, an estimated $49K.
  • MaxCyte made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3645 holding.
  • Invesco first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
  • Invesco's MaxCyte position peaked at $386K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.